Search results
Sputnik V (Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in ...
Apr 15, 2021 · Russia's COVID-19 vaccine, Sputnik V, has been approved for use in dozens of countries, and it's also under review by the European Medicines Agency. But the vaccine remains controversial.
Jun 2, 2022 · SPUTNIK LIGHT, THE FIRST COMPONENT OF SPUTNIK V, IS A SAFE AND EFFECTIVE STAND-ALONE ONE-SHOT VACCINE AGAINST COVID-19 AND AN IDEAL BOOSTER. Efficacy against infection of over 80% Efficacy as a stand-alone vaccine against infection by Delta - 70% Efficacy in the age group below 60 – over 75%
Feb 2, 2021 · Russia's Sputnik V coronavirus vaccine gives around 92% protection against Covid-19, late stage trial results published in The Lancet reveal. It has also been deemed to be safe - and offer...
The Gamaleya Research Institute, part of Russia’s Ministry of Health, developed a coronavirus vaccine known as Sputnik V or Gam-Covid-Vac.
Feb 2, 2021 · Sputnik V COVID-19 vaccine candidate appears safe and effective. Denis Logunov and colleagues report their interim results from a phase 3 trial of the Sputnik V COVID-19 vaccine in The Lancet. The trial results show a consistent strong protective effect across all participant age groups.
Mar 4, 2021 · EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine 1 developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology. The EU applicant for this medicine is R-Pharm Germany GmbH.
Jul 6, 2021 · Sputnik V — also known as Gam-COVID-Vac — was the first COVID-19 vaccine to be registered for use in any nation, and it has since been approved in 67 countries, including Brazil, Hungary,...
Aug 1, 2022 · Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in > 70 countries. Yet there is a shortage of data on this vaccine's performance...
Nov 11, 2020 · Developers of the Sputnik V vaccine announce phase III results, two days after Pfizer and BioNTech released the first compelling evidence that a vaccine can protect against coronavirus...
